Zobrazeno 1 - 10
of 25
pro vyhledávání: '"M-C. Laplace"'
Publikováno v:
Biochemical Journal. 303:227-231
Binding of 125I-thrombin to human umbilical vein endothelial cells (HUVECs) was specifically displaced by the synthetic tetradecapeptide SFLLRNPNDKYEPF, named thrombin receptor agonist peptide (TRAP), which has recently been described as a peptide mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0269074633afd7cb2176240aec818203
https://doi.org/10.1042/bj3030227
https://doi.org/10.1042/bj3030227
Autor:
P.-Y. Gueugniaud, G. Fournier, L. Besson, J.-L. Caillot, E. J. Voiglio, A. Ndiaye, Mireille Chiron, M.-C. Laplace
Publikováno v:
Journal Européen des Urgences. 20:34-35
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b34aa5d7127838049d2fadbd279fd34
https://doi.org/10.1016/j.jeur.2007.03.192
https://doi.org/10.1016/j.jeur.2007.03.192
Autor:
Paul J. Schaeffer, Jean-Marc Herbert, Danielle Gully, A Bernat, V. Prabonnaud, L. Lespy, M C Laplace
Publikováno v:
Journal of cardiovascular pharmacology. 31(4)
The novel compound SR142948A was compared with SR48692 as an antagonist of neurotensin-induced cardiovascular effects both in vitro and in vivo. SR142948A inhibited [125I]-neurotensin binding [median inhibitory concentration (IC50) = 0.24 +/- 0.01 nM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7ed977a165f8590e8dc10310955d637
https://pubmed.ncbi.nlm.nih.gov/9554803
https://pubmed.ncbi.nlm.nih.gov/9554803
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 269(2)
Thienopyridine compounds, including ticlopidine and clopidogrel, have been found to selectively inhibit adenosine 5' diphosphate (ADP)-induced platelet aggregation and adenylyl cyclase ex vivo, but the mechanism of their antiplatelet action remains t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::55a1412e0c3f2599381389d3d4a3d395
https://pubmed.ncbi.nlm.nih.gov/8182545
https://pubmed.ncbi.nlm.nih.gov/8182545
Autor:
J M, Herbert, L, Fraisse, A, Bachy, G, Valette, P, Savi, M C, Laplace, J, Lassalle, B, Roche, A, Lale, P E, Keane
Publikováno v:
Journal of lipid mediators. 8(1)
SR 27388 (N-(2-dimethylaminoethyl)-N-(3-pyridinylmethyl[4-(3,5-di(tert- butyl)-4-hydroxylphenyl)thiazol-2-yl]amine) is a potent and competitive antagonist of the binding of [3H]PAF to its receptor on rabbit platelets exhibiting an equilibrium inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5692502ba77901f8dcf2625d28bae8a
https://pubmed.ncbi.nlm.nih.gov/8257776
https://pubmed.ncbi.nlm.nih.gov/8257776
Publikováno v:
Journal of lipid mediators. 7(1)
SR 27417, the first member of a newly developed PAF antagonist series, fully and competitively displaced [3H]PAF from its high-affinity binding sites on washed rabbit and human platelets with Ki values of 57 +/- 0.02 and 50 +/- 0.8 pM (n = 3), respec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::64d8db917abd9f78f9b88fb824324f70
https://pubmed.ncbi.nlm.nih.gov/8395255
https://pubmed.ncbi.nlm.nih.gov/8395255
Autor:
C. Volle-Challier, M. Trombe, G. Morin, Françoise Bono, I. Blanc, M-C. Laplace, Dol, C. Labouret, G. Gueguen
Publikováno v:
Journal of Clinical Oncology. 28:e13524-e13524
e13524 Background: A critical step in tumor progression is the interaction of malignant and stromal cells via paracrine mechanisms. Among these stromal cells, cancer-associated fibroblasts (CAFs), ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8739db63ea4a8828cfb8b0a9e9af8f9c
https://doi.org/10.1200/jco.2010.28.15_suppl.e13524
https://doi.org/10.1200/jco.2010.28.15_suppl.e13524
Publikováno v:
Journal of lipid mediators. 5(1)
Pharmacodynamics of SR 27417, a novel, specific platelet-activating factor (PAF) antagonist was monitored with ex vivo PAF-induced platelet aggregation in the rabbit. Single per os administration of SR 27417 (5 mg/kg) resulted in complete inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d54576b3d710179c7bd2f5329a3bd7a2
https://pubmed.ncbi.nlm.nih.gov/1327264
https://pubmed.ncbi.nlm.nih.gov/1327264
Autor:
J M, Herbert, A, Bernat, G, Valette, V, Gigo, A, Lale, M C, LaPlace, L, Lespy, P, Savi, J P, Maffrand, G, Le Fur
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 259(1)
SR 27417 [N-(2-dimethylamino ethyl)-N-(3-pyridinyl methyl)[4- (2,4,6-triisopropylphenyl) thiazol-2-yl]amine] is the first member of a newly developed platelet-activating factor (PAF) antagonist series. It is a highly potent, competitive and selective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ef4b842bc30eade9f975f30b1c0acf4
https://pubmed.ncbi.nlm.nih.gov/1656029
https://pubmed.ncbi.nlm.nih.gov/1656029
Autor:
G, Bagou, M C, Laplace, B, Coronel, M C, Prud'hon, H J, Clement, D, Muguet, J F, Moskovtchenko
Publikováno v:
Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression. 32(2)
Laparoscopy without an important surgical act was executed in twenty patients. Anaesthetic protocol associated propofol, alfentanil and vecuronium. This protocol meet conditions for ambulatory patients. Only three were not suited to leave hospital si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fa594814ecd72b6984c23d98349949a9
https://pubmed.ncbi.nlm.nih.gov/1679302
https://pubmed.ncbi.nlm.nih.gov/1679302